Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Condliffe

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Thorax|February 26, 2021
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE studyAndrew J Swift, Frederick Wilson, Marcella Cogliano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Thorax|February 26, 2021
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE studyAndrew J Swift, Frederick Wilson, Marcella Cogliano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Pageof 14